Related Experiment Video
Updated: May 18, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Management of arrhythmia in patients with arterial hypertension]
Insights
This study assessed cardiovascular medication risks for arrhythmia in 123 hypertension and atrial fibrillation patients. Beta-blockers, ACE inhibitors, and preductal therapy showed potential in reducing atrial fibrillation and ventricular arrhythmia risks.
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Arterial hypertension and atrial fibrillation are common conditions associated with increased risk of cardiovascular events.
- Arrhythmic complications pose a significant threat to patients with these conditions.
- Understanding the impact of cardiovascular medications on arrhythmia risk is crucial for effective patient management.
Purpose of the Study:
- To estimate the risk of arrhythmic complications associated with cardiovascular medications in patients with arterial hypertension and recurrent atrial fibrillation.
- To investigate the role of P wave dispersion and QT interval in patients with different types of left ventricular hypertrophy.
- To evaluate the efficacy of beta-blockers, ACE inhibitors, and preductal therapy in mitigating the risk of atrial fibrillation and ventricular arrhythmia.
Main Methods:
- Prospective study design involving 123 patients.
- Assessment of P wave dispersion and QT interval characteristics.
- Analysis of therapeutic effects of beta-blockers, ACE inhibitors, and preductal agents.
Main Results:
- Cardiovascular medications were evaluated for their association with arrhythmic complications.
- Dispersion characteristics were analyzed in relation to left ventricular remodeling.
- The study identified potential benefits of specific therapies in reducing arrhythmia risk.
Conclusions:
- Certain cardiovascular medications may influence the risk of arrhythmic complications in hypertensive patients with atrial fibrillation.
- Left ventricular remodeling characteristics are relevant to arrhythmia risk assessment.
- Beta-blockers, ACE inhibitors, and preductal therapy warrant further investigation for their anti-arrhythmic potential.
Abstract:
We estimated the risk of arrhythmic complications after the use of cardiovascular medications in a prospective study including 123 patients with arterial hypertension and recurrent atrial fibrillation. Dispersion characteristics of P wave and QT interval were studied in patients with left ventricular concentric remodeling, concentric hypertrophy, and eccentric hypertrophy. The role of therapy with beta-blockers. ACE inhibitors, and preductal in the reduction of the risk of atrial fibrillation and ventricular arrhythmia was evaluated.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
Hypertension V: Nursing Management
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Aortic Regurgitation III: Medical Management